These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15307886)

  • 1. Severe cholestasis and acute renal failure related to rofecoxib.
    Linares P; Vivas S; Jorquera F; Olcoz JL; de Leon B; Oritz de Urbina J
    Am J Gastroenterol; 2004 Aug; 99(8):1622-3. PubMed ID: 15307886
    [No Abstract]   [Full Text] [Related]  

  • 2. Upper gastrointestinal toxicity of rofecoxib and naproxen.
    Gupta S
    N Engl J Med; 2001 May; 344(18):1398; author reply 1398-9. PubMed ID: 11336057
    [No Abstract]   [Full Text] [Related]  

  • 3. Rofecoxib-induced pseudoporphyria.
    Markus R; Reddick ME; Rubenstein MC
    J Am Acad Dermatol; 2004 Apr; 50(4):647-8. PubMed ID: 15034522
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse oral reactions associated with the COX-2 inhibitor rofecoxib.
    Bagán JV; Thongprasom K; Scully C
    Oral Dis; 2004 Nov; 10(6):401-3. PubMed ID: 15533219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons on prescribing and drug safety from the withdrawal of rofecoxib.
    Nelson M; Cicuttini F
    Aust Fam Physician; 2004 Dec; 33(12):965-6. PubMed ID: 15630913
    [No Abstract]   [Full Text] [Related]  

  • 6. Lessons from the withdrawal of rofecoxib.
    Dieppe PA; Ebrahim S; Martin RM; Jüni P
    BMJ; 2004 Oct; 329(7471):867-8. PubMed ID: 15485938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial hypertension induced by rofecoxib.
    Jacob S; Rajabally YA
    Headache; 2005 Jan; 45(1):75-6. PubMed ID: 15663617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Withdrawal of rofecoxib: a sign to be careful with coxibs in patients with increased cardiovascular risk].
    Bijlsma JW
    Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2162-4. PubMed ID: 15559407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure and interstitial nephritis in a patient treated with rofecoxib: case report and review of the literature.
    Szalat A; Krasilnikov I; Bloch A; Meir K; Rubinger D; Mevorach D
    Arthritis Rheum; 2004 Aug; 51(4):670-3. PubMed ID: 15334443
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib.
    Rocha JL; Fernández-Alonso J
    Lancet; 2001 Jun; 357(9272):1946-7. PubMed ID: 11425419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxicity of selective COX-2 inhibitors.
    Woywodt A; Schwarz A; Mengel M; Haller H; Zeidler H; Köhler L
    J Rheumatol; 2001 Sep; 28(9):2133-5. PubMed ID: 11550988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX-2 inhibitors and renal function in elderly people.
    Chen BH
    CMAJ; 2000 Sep; 163(5):604. PubMed ID: 11006774
    [No Abstract]   [Full Text] [Related]  

  • 13. The Vioxx debacle.
    Alpert JS
    Am J Med; 2005 Mar; 118(3):203-4. PubMed ID: 15745713
    [No Abstract]   [Full Text] [Related]  

  • 14. Was Vioxx really that dangerous?
    Park A
    Time; 2005 Feb; 165(9):52. PubMed ID: 15765852
    [No Abstract]   [Full Text] [Related]  

  • 15. Rofecoxib does not adversely affect skin graft survival in a rat model.
    Miller Q; Losken A; Harre JG; Bird ME
    Curr Surg; 2004; 61(2):227-30. PubMed ID: 15051270
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gynecomastia secondary to rofecoxib].
    Martínez JA; Tejada González P; Gutiérrez Sanpedro N; González Blanco P
    Med Clin (Barc); 2002 Jun; 118(20):798-9. PubMed ID: 12049701
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute congestive heart failure induced by rofecoxib.
    Campbell RJ; Sneed KB
    J Am Board Fam Pract; 2004; 17(2):131-5. PubMed ID: 15082672
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclooxygenase-2 inhibitors and cardiovascular risk.
    Smith ER
    Can J Cardiol; 2005 Mar; 21(3):307-8. PubMed ID: 15776124
    [No Abstract]   [Full Text] [Related]  

  • 19. Rofecoxib and the risk of adverse upper gastrointestinal effects.
    Whitney E
    JAMA; 2000 Apr; 283(15):1960; author reply 1961. PubMed ID: 10789660
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous presentation of rofecoxib-induced acute hepatitis and acute interstitial nephritis.
    Haider M; Gain E; Khadem G; Pilmore H; Yun K; Jayasinghe N; Walker R
    Intern Med J; 2005 Jun; 35(6):370-2. PubMed ID: 15892770
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.